361 related articles for article (PubMed ID: 18594554)
21. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
[TBL] [Abstract][Full Text] [Related]
22. Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions.
Kezele IB; Arnold DL; Collins DL
Mult Scler; 2008 Jul; 14(6):779-85. PubMed ID: 18611990
[TBL] [Abstract][Full Text] [Related]
23. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
24. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.
Keegan BM; Giannini C; Parisi JE; Lucchinetti CF; Boeve BF; Josephs KA
Neurology; 2008 Mar; 70(13 Pt 2):1128-33. PubMed ID: 18287567
[TBL] [Abstract][Full Text] [Related]
25. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
Placidi G; Sabatini M; Gallucci M; Sotgiu A
Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
[TBL] [Abstract][Full Text] [Related]
26. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
Chard D; Miller D
J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
[TBL] [Abstract][Full Text] [Related]
27. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
28. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
Lindberg RL; De Groot CJ; Certa U; Ravid R; Hoffmann F; Kappos L; Leppert D
J Neuroimmunol; 2004 Jul; 152(1-2):154-67. PubMed ID: 15223248
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
Charil A; Filippi M
J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
[TBL] [Abstract][Full Text] [Related]
31. Preactive lesions in multiple sclerosis.
van der Valk P; Amor S
Curr Opin Neurol; 2009 Jun; 22(3):207-13. PubMed ID: 19417567
[TBL] [Abstract][Full Text] [Related]
32. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
[TBL] [Abstract][Full Text] [Related]
33. Cortical pathology in multiple sclerosis.
Stadelmann C; Albert M; Wegner C; Brück W
Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
Filippi M; Agosta F
Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
[TBL] [Abstract][Full Text] [Related]
36. The role of MRS and fMRI in multiple sclerosis.
Tartaglia MC; Arnold DL
Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
[TBL] [Abstract][Full Text] [Related]
37. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
38. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Zhang Y; Moore GR; Laule C; Bjarnason TA; Kozlowski P; Traboulsee A; Li DK
Ann Neurol; 2013 Jul; 74(1):91-9. PubMed ID: 23939554
[TBL] [Abstract][Full Text] [Related]
39. T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients.
Holst B; Siemonsen S; Finsterbusch J; Bester M; Schippling S; Martin R; Fiehler J
Mult Scler; 2009 Jun; 15(6):701-7. PubMed ID: 19482862
[TBL] [Abstract][Full Text] [Related]
40. Gray matter involvement in multiple sclerosis.
Pirko I; Lucchinetti CF; Sriram S; Bakshi R
Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]